Financial giants have made a conspicuous bullish move on Moderna. Our analysis of options history for Moderna MRNA revealed 10 unusual trades.
Delving into the details, we found 70% of traders were bullish, while 30% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $131,720, and 6 were calls, valued at $286,888.
What's The Price Target?
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $50.0 to $160.0 for Moderna during the past quarter.
Insights into Volume & Open Interest
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Moderna's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Moderna's substantial trades, within a strike price spectrum from $50.0 to $160.0 over the preceding 30 days.
Moderna 30-Day Option Volume & Interest Snapshot
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| MRNA | CALL | SWEEP | BULLISH | 01/17/25 | $135.00 | $75.0K | 1.1K | 127 |
| MRNA | CALL | SWEEP | BULLISH | 01/17/25 | $160.00 | $65.3K | 984 | 156 |
| MRNA | CALL | SWEEP | BULLISH | 01/17/25 | $160.00 | $58.1K | 984 | 0 |
| MRNA | PUT | SWEEP | BULLISH | 04/19/24 | $75.00 | $38.7K | 1.1K | 0 |
| MRNA | PUT | SWEEP | BEARISH | 01/19/24 | $85.00 | $38.1K | 4.0K | 12 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
In light of the recent options history for Moderna, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Current Position of Moderna
- With a volume of 952,030, the price of MRNA is up 0.86% at $77.8.
- RSI indicators hint that the underlying stock may be approaching overbought.
- Next earnings are expected to be released in 92 days.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Moderna options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
